Temporal Trend in the Natural History of Ulcerative Colitis in a Country with a Low Incidence of Ulcerative Colitis from 2000 Through 2018

Overview

Journal Intest Res

Date 2020 Aug 19

PMID 32806871

Citations 11

Authors

Satimai Aniwan

Julajak Limsrivilai

Supot Pongprasobchai

Nonthalee Pausawasdi

Piyapan Prueksapanich

Natanong Kongtub

Rungsun Rerknimitr

Affiliations

Soon will be listed here.

Abstract

Background/aims: The incidence of ulcerative colitis (UC) in Thailand (crude incidence rate of 0.28 per 100,000 persons) is much lower than in the West. The burden of UC varies in different populations. The aim of this study was to evaluate the natural history of UC over the two decades in Bangkok, Thailand.

Methods: This retrospective study included patients who were diagnosed with UC between 2000 and 2018 in 2 university hospitals. To evaluate changes in the disease course, we stratified patients into 2000-2009 cohort and 2010-2018 cohort. The cumulative probability of endoscopic healing, UC-related hospitalization and colectomy was estimated using the Kaplan-Meier method.

Results: A total of 291 UC patients were followed for total of 2,228 person-years. Comparison between 2 cohorts, there were no differences in disease pattern and severity whereas an increase in the combination use of oral and topical mesalamine and the early use of thiopurine was observed. Only 1% of patients for each cohort required biologic agent at 5 years. The rate of achieving mucosal healing increased from 15% to 46% at 3 years (P< 0.01). The rate of UC-related hospitalization decreased from 30% to 21% at 5 years (P< 0.05). The rate of colectomy decreased from 6% to 2% at 5 years (P< 0.05).

Conclusions: The natural history of UC in a low incidence country was less aggressive than the West. Over the past two decades, the rates of UC-related hospitalization and colectomy have been decreasing which were similar to the West.

Citing Articles

Impact of Sarcopenia on Clinical Course of Inflammatory Bowel Disease in Korea.

Nam K, Lee J, Ko Y, Kim K, Lee H, Hong S Dig Dis Sci. 2023; 68(6):2165-2179.

PMID: 36693962 DOI: 10.1007/s10620-023-07838-z.

The epidemiology of inflammatory bowel disease in Asia and Asian immigrants to Western countries.

Aniwan S, Santiago P, Loftus Jr E, Park S United European Gastroenterol J. 2022; 10(10):1063-1076.

PMID: 36479863 PMC: 9752270. DOI: 10.1002/ueg2.12350.

Inflammatory bowel disease in Korea: epidemiology and pathophysiology.

Lee J, Eun C Korean J Intern Med. 2022; 37(5):885-894.

PMID: 35902371 PMC: 9449206. DOI: 10.3904/kjim.2022.138.

Oral beclomethasone dipropionate as an add-on therapy and response prediction in Korean patients with ulcerative colitis.

Kim K, Hong H, Oh K, Lee J, Hong S, Park J Korean J Intern Med. 2022; 37(6):1140-1152.

PMID: 35730132 PMC: 9666248. DOI: 10.3904/kjim.2022.035.

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?.

Park S Intest Res. 2022; 20(2):159-164.

PMID: 35508952 PMC: 9081986. DOI: 10.5217/ir.2021.00115.

References

Ng S, Zeng Z, Niewiadomski O, Tang W, Bell S, Kamm M . Early Course of Inflammatory Bowel Disease in a Population-Based Inception Cohort Study From 8 Countries in Asia and Australia. Gastroenterology. 2015; 150(1):86-95.e3. DOI: 10.1053/j.gastro.2015.09.005. View

Loftus Jr E, Silverstein M, Sandborn W, Tremaine W, Harmsen W, Zinsmeister A . Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000; 46(3):336-43. PMC: 1727835. DOI: 10.1136/gut.46.3.336. View

Ford A, Khan K, Achkar J, Moayyedi P . Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis. Am J Gastroenterol. 2011; 107(2):167-76. DOI: 10.1038/ajg.2011.410. View

Shah S, Khalili H, Gower-Rousseau C, Olen O, Benchimol E, Lynge E . Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries. Gastroenterology. 2018; 155(4):1079-1089.e3. DOI: 10.1053/j.gastro.2018.06.043. View

Eriksson C, Rundquist S, Cao Y, Montgomery S, Halfvarson J . Impact of thiopurines on the natural history and surgical outcome of ulcerative colitis: a cohort study. Gut. 2018; 68(4):623-632. DOI: 10.1136/gutjnl-2017-315521. View

Targownik L, Tennakoon A, Leung S, Lix L, Singh H, Bernstein C . Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis. Clin Gastroenterol Hepatol. 2017; 15(7):1061-1070.e1. DOI: 10.1016/j.cgh.2017.01.035. View

Fumery M, Singh S, Dulai P, Gower-Rousseau C, Peyrin-Biroulet L, Sandborn W . Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review. Clin Gastroenterol Hepatol. 2017; 16(3):343-356.e3. PMC: 6658168. DOI: 10.1016/j.cgh.2017.06.016. View

Vester-Andersen M, Prosberg M, Jess T, Andersson M, Bengtsson B, Blixt T . Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol. 2014; 109(5):705-14. DOI: 10.1038/ajg.2014.45. View

Jeuring S, Bours P, Zeegers M, Ambergen T, van den Heuvel T, Romberg-Camps M . Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-Based IBDSL Cohort. J Crohns Colitis. 2015; 9(10):837-45. DOI: 10.1093/ecco-jcc/jjv129. View

10.

Ng S, Tang W, Ching J, Wong M, Chow C, Hui A . Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology. 2013; 145(1):158-165.e2. DOI: 10.1053/j.gastro.2013.04.007. View

11.

Aniwan S, Harmsen W, Tremaine W, Kane S, Loftus Jr E . Overall and Cause-Specific Mortality of Inflammatory Bowel Disease in Olmsted County, Minnesota, From 1970 Through 2016. Mayo Clin Proc. 2018; 93(10):1415-1422. PMC: 6178953. DOI: 10.1016/j.mayocp.2018.03.004. View

12.

Ng S, Kaplan G, Tang W, Banerjee R, Adigopula B, Underwood F . Population Density and Risk of Inflammatory Bowel Disease: A Prospective Population-Based Study in 13 Countries or Regions in Asia-Pacific. Am J Gastroenterol. 2018; 114(1):107-115. DOI: 10.1038/s41395-018-0233-2. View

13.

Vegh Z, Burisch J, Pedersen N, Kaimakliotis I, Duricova D, Bortlik M . Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort. J Crohns Colitis. 2014; 8(11):1506-15. DOI: 10.1016/j.crohns.2014.06.004. View

14.

Mokhtar N, Muhammad Nawawi K, Verasingam J, Zhiqin W, Sagap I, Mohd Azman Z . A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia. BMC Public Health. 2019; 19(Suppl 4):550. PMC: 6565539. DOI: 10.1186/s12889-019-6858-2. View

15.

Ungaro R, Colombel J, Lissoos T, Peyrin-Biroulet L . A Treat-to-Target Update in Ulcerative Colitis: A Systematic Review. Am J Gastroenterol. 2019; 114(6):874-883. PMC: 6553548. DOI: 10.14309/ajg.0000000000000183. View

16.

Eriksson C, Cao Y, Rundquist S, Zhulina Y, Henriksson I, Montgomery S . Changes in medical management and colectomy rates: a population-based cohort study on the epidemiology and natural history of ulcerative colitis in Örebro, Sweden, 1963-2010. Aliment Pharmacol Ther. 2017; 46(8):748-757. DOI: 10.1111/apt.14268. View

17.

Ng S, Shi H, Hamidi N, Underwood F, Tang W, Benchimol E . Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017; 390(10114):2769-2778. DOI: 10.1016/S0140-6736(17)32448-0. View